Longitudinal pharmacoepidemiological and health services research for substance users in treatment: the Belgian TDI-IMA linkage

Terug naar alle onderzoeken

Samenvatting

The Belgian TDI-IMA-database links two separate databases: the Treatment Demand Indicator (TDI) and the database of the Intermutualistic Agency (IMA). The Treatment Demand Indicator is measuring incidence of people with substance use disorders entering drug treatment. The IMA-database covers data, collected in the framework of the compulsory Belgian health care and benefits insurance program, on reimbursed medication and the use of reimbursed health services. The linkage results in pharmacoepidemiological and health service data for people who were in treatment for substance use disorders and for a group of comparators.

The TDI-database was linked to the IMA-database for the period between 01/01/2008 and 31/12/2017, based on the national identification number of patients who have been in alcohol or drug treatment between 01/01/2011 and 31/12/2014. Through this linkage, pharmacoepidemiological and health service data became available for at least three years before the first registered episode in the TDI-database till at least three years after the first episode. For each person in TDI four comparators, who were not in specialized treatment, were matched on age, sex and place of residence.

The TDI-IMA-database allows for an analysis of health seeking behavior and health care pathways of people before and after they entered specialized alcohol and drug treatment.

Output

Van Baelen, L., De Ridder, K., Antoine, J., & Gremeaux, L. (2018). Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011–2014): a cross-sectional study. Archives of Public Health, 76(1), 17.

Van Baelen, L., De Ridder, K., Antoine, J., & Gremeaux, L. (2018). Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage. Archives of Public Health, 76(1), 3.

Online artikels & rapporten

Contact

Sciensano
Luk Van Baelen

Algemene info

Looptijd

Startdatum 01/01/2016
Einddatum 31/12/2020
Doorlopend project

Methode

Secundaire dataanalyse

Type

Longitudinaal onderzoek

Gefinancierd door

Eigen middelen (los van subsidies)

Product

Alcohol
Illegale drugs
Psychoactieve medicatie
Polygebruik

Discipline

Epidemiologisch onderzoek

Regio

Belgisch

Status

Lopend

Datum laatste wijziging: 07/08/2018
Dit item aanpassen